SCHEMBL7187428

SCHEMBL7187428

CCOc1ccccc1PC(=O)c1c(OC)cc(OC)cc1OC.[LiH]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.46
MAPT P10636 2/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
ATM Q13315 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.41
MAPK1 P28482 2/20 0.41
USP2 O75604 1/20 0.41
CYP3A4 P08684 1/20 0.41
KMT2A Q03164 2/20 0.41
KCNK3 O14649 1/20 0.41
KCNK9 Q9NPC2 1/20 0.41
MEN1 O00255 1/20 0.40
CALM1 P0DP23 2/20 0.40
GAA P10253 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7181649 0.95 MAPT (0.44) TSHRMAPTKDM4ELMNAHPGD
SCHEMBL7188662 0.89 HPGD (0.43) TSHRMAPTKDM4ELMNAHPGD
SCHEMBL7188860 0.89 TSHR (0.43) TSHRMAPTKDM4ELMNAHPGD
SCHEMBL7184615 0.88 MAPT (0.40) TSHRMAPTKDM4ELMNAHPGD
SCHEMBL7180673 0.87 KDM4E (0.45) TSHRMAPTKDM4ELMNAHPGD
SCHEMBL7187396 0.86 LMNA (0.46) TSHRMAPTKDM4ELMNAHPGD
Lithium SCHEMBL7180686 0.85 KDM4E (0.45) TSHRMAPTKDM4ELMNAHPGD
SCHEMBL7188521 0.84 KCNK3 (0.41) TSHRMAPTKDM4ELMNAHPGD
SCHEMBL7187030 0.84 SMN1; SMN2 (0.50) TSHRMAPTKDM4ELMNAHPGD
SCHEMBL7735413 0.81 MAPT (0.43) TSHRMAPTKDM4ELMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 TSHR 984/4885MAPT 4870/4885KDM4E 3226/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 TSHR 1273/4885MAPT 4859/4885KDM4E 2651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.